Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedRespond is a private digital health and healthcare communications company that provides AI-enabled conversational patient engagement and education tools for healthcare providers, biopharma clients, advocacy groups, pharmacies, and professional associations. The company originated as a Carnegie Mellon University spin-out and commercialized a platform that combines artificial intelligence, search, and streaming media to deliver interactive, personalized health information and training. Its offerings are used for surgical education, chronic care management, vaccine support, medication counseling, continuing education, and clinical trial patient education. Unlike a drug-development biotech, MedRespond appears to be a commercial-stage healthcare technology vendor focused on patient communication workflows rather than therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedRespond.